Drug Database
Back to search

Germany· DE-A57-2c0c1bca7e5fffaf

Petnidan Saft

A ethosuximide product containing ethosuximide, registered in Germany by Desitin Arzneimittel Gmbh. The same ATC class is registered in 16 of our 19 countries.

ATC N03AD01

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedPetnidan SaftATCN03AD01REGISTER NO.DE-A57-2c0c1bca7e5fff…PACKS LISTED0CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ethosuximideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ethosuximide is registered in 16 of 19 countries.

Countries holding a registration under ATC N03AD01 (ethosuximide), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 8 of them publish a price we can compare per daily dose
Search ethosuximide products by name

Ethosuximide · ATC N03AD01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ethosuximide costs, country by country.

Normalised to the WHO defined daily dose (1.25 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Ethosuximide · price per daily dose (1.25 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.83
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)
Active substance
Ethosuximide
Manufacturer
Desitin Arzneimittel Gmbh
Country
Germany (DE)
ATC code
N03AD01
ATC class
Ethosuximide
Defined daily dose
1.25 g, O
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

124 interactions on record for ethosuximide.

Graded by severity as the source publishes them — 124 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ethosuximide against other medicinesHow interaction checks work

Ethosuximide · interactions on record

124 records

  • 124 moderate

Most severe, free to view

  • MetoclopramideA03FA01moderate
  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate
  • DronabinolA04AD10moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ethosuximide in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ethosuximide products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Austria · Ethosuximid Neuraxpharm, Petinimid
  • Belgium · Zarontin
  • Bulgaria · Petinimid
  • Czechia · Petinimid
  • Denmark · Ethosuximide Orifarm, Ethosuximide Strides
  • Spain · Etosuximida Faes
  • France · Zarontin
  • United Kingdom (Northern Ireland) · Emeside, Epesri
  • Croatia · Suxital
  • Ireland · Zarontin
  • Italy · Etosuccimide Glenmark, Zarontin
  • Luxembourg · Zarontin
  • Netherlands · Ethosuximide Aurobindo, Ethosuximide Strides
  • Norway · Ethosuximide Orifarm, Ethosuximide Strides
  • Poland · Petinimid
  • Sweden · Ethosuximide Orifarm, Ethosuximide Strides
  • Slovenia · Suxital
  • Slovakia · Petinimid Cps, Petnidan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f0d15c33-4486-47cd-9c0a-a44cc98e7977
GET /v1/drugs/f0d15c33-4486-47cd-9c0a-a44cc98e7977?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Ethosuximide",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}
API referenceMCP serverPlans

See everything about ethosuximide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console